Last updated on August 2018

Moderate to Severe Plaque Psoriasis

Brief description of study

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects with Moderate-to-Severe Plaque Psoriasis.


Clinical Study Identifier: TX210462

Contact Investigators or Research Sites near you

Start Over

Diana, Recruitment Specialist

Direct Helpers Research Center
Hialeah, FL USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.